Cited by 175Cell Adhesion Molecules ResearchNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration Mechanisms

Integrins as receptor targets for neurological disorders

Open access
Wu, Xin, Reddy, Doodipala Samba·2012·Pharmacology & Therapeutics

Abstract

This review focuses on the neurobiology of integrins, pathophysiological roles of integrins in neuroplasticity and nervous system disorders, and therapeutic implications of integrins as potential drug targets and possible delivery pathways. Neuroplasticity is a central phenomenon in many neurological conditions such as seizures, trauma, and traumatic brain injury. During the course of many brain diseases, in addition to intracellular compartment changes, alterations in non-cell compartments such as extracellular matrix (ECM) are recognized as an essential process in forming and reorganizing neural connections. Integrins are heterodimeric transmembrane receptors that mediate cell-ECM and cell-cell adhesion events. Although the mechanisms of neuroplasticity remain unclear, it has been suggested that integrins undergo plasticity including clustering through interactions with ECM proteins, modulating ion channels, intracellular Ca(2+) and protein kinase signaling, and reorganization of cytoskeletal filaments. As cell surface receptors, integrins are central to the pathophysiology of many brain diseases, such as epilepsy, and are potential targets for the development of new drugs for neurological disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2011.12.008

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The integrin and Alzheimer disease-presenilin signaling pathways are well-known gene routes in the development of abnormal aggressive behaviors.

    “Among the top enriched up-regulated pathways in the aggressive Lidia group, the integrin and Alzheimer disease-presenilin signaling pathways are well-known gene routes in the development of abnormal aggressive behaviors [48] (Table 3).”
  • Increased expression of integrins contributes to imbalanced synaptic function in specific pathological conditions, such as Alzheimer disease and schizophrenia, both often accompanied by episodic aggression and violence.

    “Increased expression of integrins contributes to imbalanced synaptic function in specific pathological conditions, such as Alzheimer disease and schizophrenia, both often accompanied by episodic aggression and violence [48].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 202 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Wu X Gui PC Li J Balasubramanian B Braun AP Zamponi GW 2010a Regulation of cardiac (Cav1.2a), smooth muscle (Cav1.2b) and neuronal (Cav1.2c) L-type calcium channels by alpha (5) beta (1) integrin activation Texas A&M Health Science Center Research Symposium College Station, Texas

Cited by

Sorted by citations

Authors
Wu, X., & Reddy, D. S.
Affiliations
Texas A&M Health Science Center (US)
Corresponding author
Reddy, Doodipala Samba
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2012-04
Volume
134
Issue
1
Pages
68-81
ISSN
0163-7258 (ISSN-L)
OpenAlex
W2015445832
Cited by
175
References
202
Citations by year
2026: 12 · 2025: 19 · 2024: 12 · 2023: 16 · 2022: 12 · 2021: 17 · 2020: 12 · 2019: 21 · 2018: 14 · 2017: 5 · 2016: 10 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 4
FWCI
0.79
Type
journal article
Language
en
Open access
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS051398, NS051398)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
integrins, neuroplasticity, neurological disorders, extracellular matrix, cell-cell adhesion, cell-matrix adhesion, integrin clustering, epilepsy, traumatic brain injury, seizures, therapeutic target, drug delivery, cytoskeletal remodeling, calcium signaling, protein kinase signaling
MeSH terms
Animals, Brain Diseases, Humans, Integrins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review